CAS: 63-89-8; (R)-2,3-Bis(Palmitoyloxy)Propyl (2-(Trimethylammonio)Ethyl) Phosphate

该化合物是生物化学和生物物理中常用的磷素,特别是在细胞膜和脂质研究中,其特点是两条棕榈酸链,是饱和脂肪酸,有助于其在生理温度下的结构稳定性和僵硬性;DPPC有一个甘油脊椎,配有与第三碳相连的磷酸酯组,该组又与一胆碱性细胞相连,使它成为Zwitter分子;这种独特的结构使DPPC能够在水深环境中形成双层,模拟生物膜;它呈现一个阶段性过渡温度,低于凝胶状,高于其向液体状态的转化,影响膜的流动性和易感性;DPPC还用于药物运载系统,并用作各种药物配方的表面活性剂,因为其稳定乳胶和增强盐分泌素的能力,从而能够形成双层细胞分子;这种独特的结构使DPPC在水态中形成一种盐状,表明其盐状体-89化合物的特性.

结构式图片

相似化合物

76343-22-1 816-94-4 18194-24-6

上下游产品

palmitic anhydride 1-palmitoyl-sn-glycero-3-phosph°Choline choline tosylate triethylammonium 1,2-di-O-hexadecanoyl-sn-glycerol 3-hydrogenphosphonate R)-1-(ethoxy-hydroxy-phosphoryloxy)-2,3-bis-palmitoyloxy-propane; sodium-salt(R)-1-(ethoxy-hydroxy-phosphoryloxy)-2,3-bis-palmitoyloxy-propane; sodium-salt choline

合成工艺路线路线简述

    Alkaline Earth Salt Of/the/ Methylsulfuric Acid置于乙醇,铂体系中,化学反应生成 二棕榈酸磷脂酰胆碱
    参考文献:An Improved Procedure For The Synthesis Of Enantiomeric α-Lecithins
    标题:An Improved Procedure For The Synthesis Of Enantiomeric α-Lecithins
    摘要:
    DOI:10.1021/ja01121A039

    海关参考信息

    专利信息


    专利号:US-2024294462-A1
    优先权日:2023-02-15
    标题:Method for the Synthesis of Ionizable Lipids Using a Doubly Alkylated Intermediate
    发明人:SAADATI FARIBA; TRAN HUY; CIUFOLINI MARCO; ATMURI N D PRASAD
    权利人:NANOVATION THERAPEUTICS INC
    摘要:Provided herein is a method for the preparation of ionizable, cationic amino lipids using a doubly alkylated nucleophilic intermediate to produce a ketone. The ketone, or a corresponding alcohol, is subjected to one or more synthesis steps to add an ionizable moiety thereto. The method can be advantageously employed for the synthesis of unsymmetrical analogues of the above lipids that would be considerably more difficult to make by alternative strategies. The method can also be used to prepare symmetrical ionizable, cationic amino lipids with fewer steps and/or with the use of fewer hazardous chemicals than known synthesis methods.

    专利号:US-2012190064-A1
    优先权日:2004-10-01
    标题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
    发明人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA
    权利人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA; LIFE TECHNOLOGIES CORP
    摘要:Compositions, methods and kits for in vitro systems for synthesis of biomolecules such as polypeptides, are provided herein. Cell extracts that provide enhanced yields of soluble proteins using in vitro protein synthesis methods are provided. The invention also includes methods for producing high yields of proteins by the addition of a feeding solution that includes amino acids and an energy source to an ongoing in vitro synthesis system. The invention also includes methods of using a high-yield in vitro synthesis system to produce large quantities of proteins with incorporated labeled amino acids for analysis by methods such as by NMR. The invention further includes vectors for enhanced production of proteins from nucleic acid templates using in vitro synthesis systems.

    专利号:US-12383499-B2
    优先权日:2018-01-01
    标题:Scale up synthesis of silicasome nanocarriers
    发明人:NEL ANDRE E; MENG HUAN; LIU XIANGSHENG
    权利人:UNIV CALIFORNIA
    摘要:In order to facilitate the approval and commercialization of silicasome drug delivery systems (e.g. irinotecan silicasomes) it is necessary to scale up synthesis of the drug-loaded silicasomes. In this regard, it was discovered that the synthesis protocols used for laboratory synthesis of drug-loaded silicasomes (e.g., 500 mg/batch) do not scale to large scale silicasome production, because the resulting products were too heterogeneous for use as pharmaceuticals. Accordingly, new methods are provided herein that effectively afford the large-scale production of mesoporous silica nanoparticles (MSNPs) and lipid bilayer coated MSNPs (silicasomes).

    专利号:WO-2012001578-A1
    优先权日:2010-06-29
    标 题 :Single-step synthesis of iron oxide nanoparticles
    发明人:BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN
    权利人:KONINKL PHILIPS ELECTRONICS NV; BURDINSKI DIRK; HAEX NICOLE PETRONELLA MARTIEN
    摘要:The invention provides methods for the synthesis of iron oxide nanoparticles and the particles obtainable by these methods. The particles can be used as tracer materials for magnetic particle imaging and for Magnetic Particle Spectroscopy (MPS). The method for the synthesis of these particles comprises the steps: (i) dissolving at least one water-soluble iron salt and at least one water-soluble stabilizer in water to form a reaction batch, (ii) adding at least one base to the reaction batch to yield a pH of 10 to 13, and (iii) exposing the reaction batch to a reaction temperature T R for a defined period of time DT, wherein T R ≥ 110°C, to obtain the iron oxide nanoparticles.

    专利号:US-6451543-B1
    优先权日:1998-08-31
    标题:Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
    发明人:KOCHENDOERFER GERD G; HUNTER CHRISTIE L; KENT STEPHEN B H; BOTTI PAOLO
    权利人:GRYPHON SCIENCES
    摘要:The present invention relates to methods and compositions for lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides that are incorporated in a lipid matrix. The invention is exemplified in production of a prefolded membrane polypeptide embedded within a lipid matrix via stepwise chemoselective chemical ligation of unprotected peptide segments, where at least one peptide segment is embedded in a lipid matrix. Any chemoselective reaction chemistry amenable for ligation of unprotected peptide segments can be employed. Suitable lipid matrices include liposomes, micelles, cell membrane patches and optically isotropic cubic lipidic phase matrices. Prefolded synthetic and semi-synthetic membrane polypeptides synthesized according to the methods and compositions of the invention also permit site-specific incorporation of one or more detectable moieties, such as a chromophore, which can be conveniently introduced during synthesis. The methods and compositions of the invention have multiple uses. For example, they can be used to assay ligand binding to membrane polypeptides and domains comprising a receptor, and thus are extremely useful for structure/function studies, drug screening/selection/design, and diagnostics and the like, including high-throughput applications. The methods and compositions of the invention are particularly suited for FRET analyses of previously inaccessible membrane polypeptides.

    专利号:WO-2004011474-A1
    优先权日:2002-07-31
    标题:Universal support media for synthesis of oligomeric compounds
    发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    权利人:ISIS PHARMACEUTICALS INC; GUZAEV ANDREI P; MANOHARAN MUTHIAH; RAVIKUMAR VASULINGA T; KUMAR RAJU K
    摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotide and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.
    上海艾韦特医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.avt-cn.com
    电话: 021-58515280 13816222911👤
    📞上海艾韦特医药科技有限公司 ⚠️参考联系方式

    销售电话:021-58515280 13816222911
    邮箱:nelson@avt-cn.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江西伯业医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.boyepharm.com
    企业联系电话:18971341812(同微信);QQ1564214480👤
    📞江西伯业医药科技有限公司 ⚠️参考联系方式
    联系人:徐双凤
    电话:18971341812(同微信);QQ1564214480
    手机:18971341812(同微信);QQ1564214480

    邮箱:1973211433@qq.com
    通信地址: 江西省新余市渝水区解放东路19号
    邮编: 430000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江西省新余市渝水区解放东路19号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Dechant KL, Faulds D. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome. Drugs. 1991 Nov;42(5):877-94. doi: 10.2165/00003495-199142050-00009. 29(12):46. 6(4):358-69. doi: 10.2165/00019053-199406040-00003. 6(6):563-77. doi: 10.2165/00019053-199406060-00009. International Surfaxin Collaborative Study Group. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics. 2005 Apr;115(4):1018-29. doi: 10.1542/peds.2004-2183. 1(3):219-43. doi: 10.2165/00128072-199901030-00006. 51(2):226-37. doi: 10.2165/00003495-199651020-00004. 30(4):389-98. doi: 10.1177/106002809603000412. Doc No
    28:[3886 words; 47 paragraphs]. 341(8860):1603. doi: 10.1016/0140-6736(93)90745-3. 20(4):697-710. 89(11):1086-1092. doi: 10.1007/s12098-022-04166-4. Epub 2022 Jun 1. 4(2):139-45; discussion 146-7. doi: 10.2165/00151829-200504020-00008. 11(10):880-2. 15(3):2064-2070. doi: 10.1021/acs.jctc.8b00933. Epub 2019 Feb 4.
    11:569727. doi: 10.3389/fimmu.2020.569727.

    合成参考文献


    摘要:https://www.biorxiv.org/content/10.1101/2020.02.11.944900v1
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知